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Background: Living donor liver transplantation (LDLT) is a valuable and legitimate treatment for patients with end-
stage liver disease. Computed tomography (CT) has proven to be an important tool in the process of donor
evaluation. The purpose of this study was to evaluate the significance of CT in the donor selection process.
Methods: Between May 1999 and October 2010 170 candidate donors underwent biphasic CT. We retrospectively
reviewed the results of the CT and liver volumetry, and assessed reasons for rejection.
Results: 89 candidates underwent partial liver resection (52.4%). Based on the results of liver CT and volumetry 22
candidates were excluded as donors (31% of the cases). Reasons included fatty liver (n = 9), vascular anatomical
variants (n = 4), incidental finding of hemangioma and focal nodular hyperplasia (n = 1) and small (n = 5) or large for
size (n = 5) graft volume.
Conclusion: CT based imaging of the liver in combination with dedicated software plays a key role in the process
of evaluation of candidates for LDLT. It may account for up to 1/3 of the contraindications for LDLT.
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Since the first report of successful living donor liver
transplantation (LDLT) in 1990 [1], LDLT has become a
valuable treatment for patients with end-stage liver dis-
ease who cannot receive deceased donor livers. Particu-
larly in children who need a small sized graft, the use of
liver transplantation is limited due to shortage of
deceased donor organs.
Since the safety of volunteer living donors in LDLT
has always been considered paramount, evaluation of
potential candidates plays a crucial role to confirm suit-
ability and to identify possible contraindications. Each
transplant center has its own protocol for living donor
evaluation, which typically includes a comprehensive
medical and psychosocial examination as well as non-* Correspondence: ringe.kristina@mh-hannover.de
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reproduction in any medium, provided the orinvasive imaging and other studies to assess size, anat-
omy and function of the liver.
Both, contrast enhanced computed-tomography (CT),
and magnetic resonance imaging (MRI) have been
shown to be suitable diagnostic tools, and are being used
concurrently in different centers throughout the world.
Imaging in a living liver donor has three objectives: (1)
to identify any intraparenchymal lesions or abnormalities
like fatty changes; (2) to visualize the extra- and intrahe-
patic vascular and biliary anatomy; and (3) to determine
the size of the whole liver and calculate the graft and
remnant liver volumes. The main advantage of CT over
MRI is based on a higher spatial resolution and manifold
post-processing possibilities [2,3].
The preoperative imaging process in LDLT is demand-
ing and conscientious. Radiologists play a key role in fil-
tering and providing the required information to
surgeons. In addition, they may help to identify unsuit-
able donors and avoid unnecessary or invasive studies
and procedures. The purpose of our study was thus totd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Table 2 Recipient demographic data
Number of potential recipients 143
Patient age 4 months - 71 years (mean 15.3 years)








Acute liver failure 2
Other 14
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process, and therefore to reflect the radiologists impact
on donor selection.
Materials and methods
This retrospective study was approved by the ethics
committee of Hannover Medical School with a waiver of
consent granted.
Candidate donors and recipients
Between May 1999 and October 2010 170 candidate
donors (92 female, 78 male, mean age 39 years, range
18-61 years) underwent biphasic CT of the liver
(Table 1). In addition, all donors had routine ultrasound
examination. Further, biliary anatomy was assessed
intraoperatively. The recipients were 143 patients (53 fe-
male, 90 male; 99 children, 44 adults) with a mean age
of 15.3 years (4 months-71 years) (Table 2). In 121 reci-
pients one donor was evaluated by means of CT, in 19
recipients two donors, in 1 recipient three donors, and
in 2 recipients four donors, respectively. Most common
underlying diseases were biliary atresia in children
(n = 69), liver cirrhosis (n = 19), and hepatocellular car-
cinoma respectively hepatoblastoma (n = 22). We retro-
spectively reviewed the results of the CT and liver
volumetry, and reasons for rejection were assessed.
Image acquisition
Until October 2005 CT was performed using a 4-channel
multi-detector row CT (Somatom Plus 4A, Siemens,
Erlangen, Germany). To keep radiation dose levels as low
as possible, a native CT scan was not acquired. 150 ml of
a nonionic iodinated contrast agent (Ultravist 300W,
Bayer Schering Pharma, Berlin) followed by a 40 ml sa-
line flush (NaCl 0.9%) were injected at a flow of 3-5 ml
/sec. Biphasic image acquisition of the liver started 5 sec-
onds after bolus detection in the abdominal aorta for the
arterial phase. Portal-venous phase scanning followed
after an interscan delay of 15 seconds. The parameters
were identical for both scans: 3 mm slice collimation, a
table feed of 5 mm per gantry rotation, and 2 mm recon-
struction interval. Starting in October 2005 CT was per-
formed using a 64-channel scanner (Lightspeed VCT, GETable 1 Candidate donor demographic data
Number of potential donors 170
Donor age (years) 18-61 (mean 39)
Donor sex (male / female) 78 / 92
Performed LDLT 89 Mean graft volume [ml]
Left lateral 57 277 (SD 63)
Full left lobe 1 414
Right lobe 31 1134 (SD 317)
LDLT = living donor liver transplantation; SD= standard deviation.Medical Systems, USA). Multiphase scanning was per-
formed after intravenous injection of 120 ml of a nonio-
nic iodinated contrast medium (Imeron 400W, Nycomed
GmbH, Germany) followed by a 50 ml saline flush (NaCl
0,9%) at a rate of 5 ml/sec. Arterial dominant phase
images were obtained 15 seconds after bolus detection in
the abdominal aorta, portal-venous scanning followed
after an interscan delay of 25 seconds. Again, the para-
meters were identical for both scans: 1.25 mm slice colli-
mation, a table feed of 39.37 mm per gantry rotation, and
1 mm reconstruction interval.
Image analysis and postprocessing
Postprocessing was performed on a commercially avail-
able workstation (ADW 2.2-4.4, GE Healthcare, USA).
In addition to multiplanar reformations, maximum in-
tensity projections (MIP) and 3D volume rendered (VR)
images were used for evaluation of the vascular anatomy
and identifying relevant anatomic variants. Relevant
steatosis was suspected when pronounced liver-spleen
attenuation was observed or the attenuation of the liver
parenchyma was less than the attenuation of the muscle,
as suggested by previous studies [4,5]. In the relevant
donors, liver biopsy was performed in order to confirm
the degree of steatosis. Volume calculations of liver seg-
ments were performed using dedicated software (Hepa-
VisionW: MeVis, Germany) (Figures 1 and 2) [6,7]. Liver
volumetry and segmentation was performed by an
experienced radiologist, and subsequent drawing of the
resection plane in agreement with the respective trans-
plant surgeon.
Results
After completion of the evaluation process living donor
liver transplantation was realized in 89 cases, respect-
ively 52.4% (Figure 3). These included transplantation of
the left lateral liver (segments 2 and 3) in 57 patients,
transplantation of a full left lobe (segments 1-4) in one
Figure 1 Total liver volume was calculated using dedicated
software (HepaVisionW, MeVis, Germany) by tracing around the
margins of the hepatic parenchyma on selected transversal
slices. Slices in between were interpolated. Large vessels as the
inferior vena cava and extrahepatic portal vein were excluded. The
cross sectional area (cm2) within the region of interest was
determined, and all individual areas were summed yielding the total
liver volume (cm3).
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5-8) in 31 patients (Table 1). For the right liver graft the
resection line ran approximately 1 cm to the right of the
middle hepatic vein. In one donor, a focal nodular hyper-
plasia was resected simultaneously, which was inciden-
tally detected on the CT scan (Figure 4). In theremaining candidates surgery was not carried out either
because a graft from a deceased donor became available
(n = 28), death of the recipient before transplantation
(n = 9) or because the donor was rejected for LDLT
(n = 35). In 9 patients the evaluation process is still in
progress and LDLT is planned.
Based on the results of contrast enhanced CT scan and
liver volumetry, 22 candidates were excluded as donors.
Reasons included signs of a fatty liver (n = 9) which was
later on confirmed by biopsy, vascular anatomical var-
iants (n = 4), coincidental finding of hemangioma and
focal nodular hyperplasia (n = 1) or small for size (n = 5)
or large for size (n = 5) graft volume, respectively. In this
context small for size was defined as GRBR (graft weight
to recipient to recipient body weight ratio; synonym
GRWR) <0.8%. In the five potential donors calculated as
large for size the relevant grafts were left lateral segments
designated for children aged 5 months to 5 years with a
calculated graft volume of 345 to 511 ml. The vascular
variants encountered were as follows: right hepatic artery
arising from the superior mesenteric artery, left hepatic
artery arising from the celiac trunk in combination with
a right hepatic artery arising from the superior mesen-
teric artery (Figure 5), and atypical venous drainage of
segment 5. Candidates were further excluded in the
course of the evaluation process as donors due to med-
ical reasons, such as profound arterial hypertension and
unexplained elevation of transaminases, as well as social
or respectively ethical reasons (e.g. poor prognosis of the
recipient).
Discussion
To meet the need of increasing potential liver transplant
recipients, alternative procedures have been developed,
such as reduced-size, split and living donor liver trans-
plantation [8]. LDLT has two major advantages over
transplantation from a brain-dead donor: excellent graft
quality and reduced ischemia-reperfusion injury [9].
On the other hand, donor safety is the first priority. It
is important to keep in mind that LDLT should only be
performed if the risk to the donor is justified by expect-
ation of an acceptable outcome in the recipient. Overall
donor morbidity is estimated to be approximately 35%,
including bile leakage, wound infection and ileus [10]. A
recent survey identified 33 living liver donor deaths, in-
cluding 3 donors who succumbed after an attempted
rescue with a liver transplant [11].
Preoperative imaging of the liver is essential in order
to identify and minimize the individual risk of the poten-
tial donor. It is further determining for graft survival
and in preventing vascular complications. The imple-
mentation of imaging studies of the liver, the choice of
the imaging modality (CT, MRI, ultrasound, angiog-
raphy, e.g.) as well as the timing of imaging (early in the
Figure 2 Calculation of graft and remnant liver volume after virtual resection using HepaVisionWsoftware (MeVis, Germany).
Visualization of the resection line on transversal slices (a) and in 3D including hepatic veins (b).
Ringe et al. BMC Medical Imaging 2012, 12:21 Page 4 of 7
http://www.biomedcentral.com/1471-2342/12/21evaluation process vs. in the end) varies in different
transplant centers.
MRI is undoubtedly becoming more significant in the
course of living donor liver evaluation, due to the devel-
opment of hepatobiliary-specific contrast agents and
new imaging techniques (such as chemical shift imaging,
MR spectroscopy), opening up new possibilities for com-
prehensive imaging of the liver [12,13]. However, avail-
ability of MR is still an issue.
The purpose of this retrospective study was therefore
to review the radiologist’s contribution to the process of
evaluation of donors for LDLT by means of contrast
enhanced CT, especially since we can look back on a
large group of donors being evaluated with this tech-
nique over a significant period of time. Based on the
results of the CT scan and liver volumetry in our study
22 candidates were excluded as donors, which accounts
for nearly one third (31%) of the cases in which LDLT
was not carried out. This relatively high number could
be an argument to perform CT imaging early rather
than late in the process of donor evaluation. The overall










Results of CT/ volumetry
n= 22
- fatty liver (n=9)
- vascular variants (n=4)
- FNH, hemangioma (n=1)
- small for size (n=5)
- large for size (n=5)
(in two patients combination of two factors)
Ethi
Figure 3 Follow-up of candidate donors being evaluated for LDLT byin previous studies to be in the range from 1383-2569€
[14], in some centers even as high as 4589€ [15]. Early
implementation of CT imaging (estimated costs of ap-
proximately 400-600€) in the evaluation process might
therefore prevent further studies in unsuitable donors
and reduce costs.
Nine candidate donors were excluded because CT
indicated steatosis of the liver, which was confirmed with
ultrasound and liver biopsy. Fatty infiltration in hepatic
grafts is known to be an important risk factor for pri-
mary graft nonfunction in deceased donor liver trans-
plantation as well as in LDLT [16,17]. Liver grafts with a
mild degree of fatty changes can be used for liver trans-
plantation without ill effect, but liver grafts with moder-
ate or severe degree of fatty changes have been found to
have a negative effect on post transplant graft function
and patient survival [17,18]. Marcos et al estimated that
1% of hepatic steatosis can decrease the functional graft
mass by 1% [19]. More recently the same group pub-
lished a series in which no impairment in function was
found in either the living donor or the recipient using
grafts containing less than 30% steatosis [20]. In our a CT scan for evaluation




cal / social reasons
n= 6
Deceased donor liver
transplantation n = 28
Death of recipient
before transplantation n = 9
means of contrast enhanced CT.
Figure 4 Donor candidate in whom the left lateral segments where resected for LDLT. Simultaneously, a FNH in the right lobe, incidentally
detected in the CT scan, was resected.
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changes in the liver graft is 30%.
10 candidate donors were excluded because of the
results of liver volumetry, depicting either small (n = 5)
or large for size (n = 5) graft volume. Preoperative assess-
ment of total, graft and remnant liver volume is of ut-
most importance, since inadequate liver mass can
influence patient and graft survival. There are several
formulas for calculating total liver volume depending on
the body weight, body surface and gender [21,22].
Results do not always correlate and liver volume is often
overestimated [23]. Depending on the individual method
used, it is considered acceptable when the ratio between
graft weight and recipient body weight or between graft
volume and the estimated standard liver volume of the
recipient are at least 0,8% and 40%, respectively [24].
In case of left lateral donation remnant liver volume is
usually safe for the donor, whereas graft size might be
too large in small children. In our study this led to theFigure 5 Maximum Intensity Projections (a,b) and 3D volume rendere
from the celiac trunk (TC) and a right hepatic artery (RHA) arising fro
graft volume was large for size.exclusion of five donors. Especially in case of right liver
donation remnant liver volume might be too small (risk-
ing acute liver failure of the donor), whereas graft size
might as well be too small resulting in a “small-for-size
-syndrome” in the recipient, characterized by hepatocyte
ballooning, steatosis, centrilobular necrosis and paren-
chymal cholestasis [25]. This led to the exclusion of
three donors who were evaluated for donation of the
right lobe.
CT is further important in assessment of vascular hep-
atic anatomy. Certain anomalies may require modifica-
tion of the surgical procedure, while others might be a
contraindication for surgery [26]. Other vascular var-
iants may even be advantageous, e.g. a displaced right
artery arising from the superior mesenteric artery in case
of right donation. Due to the greater variability of the
right hepatic vascular anatomy right hepatectomy can be
one of the most challenging surgical procedures. In
addition to the arterial supply of the graft and thed image (c) in a candidate with a left hepatic artery (LHA) arising
m the superior mesenteric artery (*). LDLT was not carried out, as
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drainage in order to prevent venous congestion. In our
study 4 candidate donors were excluded from LDLT be-
cause of various vascular anatomic variants. Even though
our reported vascular variants do not present absolute
contraindications, in these specific cases LDLT would
have been involved with an increased surgical complex-
ity and an increased risk of graft failure respectively
complications in the donor as well as in the recipient. It
is important that anatomic vascular variants are assessed
in context with the planned resection, and the decision
whether a specific donor is suited for a specific recipient
is in the end up to the responsible transplant surgeon.
Conclusions
The use of imaging studies in the process of liver donor
evaluation, specifically the choice of the imaging modal-
ity (CT, MRI, ultrasound, or angiography) as well as the
timing of imaging (early in the evaluation process vs. in
the end) has significant implications for the subsequent
evaluation process. In our long-term experience, CT
based imaging of the liver in combination with dedicated
software plays a key role in the process of evaluation of
candidates for LDLT. In this series almost 1/3 of donor
candidates were rejected because of CT findings. CT can
help to reduce the risk for donor and recipient by exclu-
sion of unsuitable donor livers. If performed early during
the evaluation process it can also prevent unnecessary
studies, further reducing the risks and costs.
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